Literature DB >> 34916107

National Rates of Lower Extremity Amputation in People With and Without Diabetes in a Multi-Ethnic Asian Population: a Ten Year Study in Singapore.

Tessa Riandini1, Deanette Pang2, Matthias P H S Toh3, Chuen S Tan1, Andrew M T L Choong4, Zhiwen J Lo5, Sadhana Chandrasekar5, E Shyong Tai6, Kelvin B Tan7, Kavita Venkataraman8.   

Abstract

OBJECTIVE: Population level data from Asia on amputation rates in people with and without diabetes are extremely limited. Hence it is unclear how the rising diabetes prevalence in Asia has affected the amputation burden. The present study examined national amputation rates in people with and without diabetes in Singapore from 2008 to 2017 in the context of increasing diabetes prevalence and health system changes.
METHODS: This was a retrospective observational study using national population data for ages 16 - 100 years obtained from the Ministry of Health Singapore administrative datasets. Age sex standardised major and toe/ray amputation rates per 100 000 people with diabetes and per 100 000 people without diabetes were calculated. Rates were calculated overall and in each ethnic group (Chinese, Malay, Indian, Others), with trends over time calculated using joinpoint trend analysis. In addition, age specific rates, relative risk (RR) of amputation in diabetics compared with non-diabetics and proportion of amputations in the population attributable to diabetes were also calculated.
RESULTS: Between 2008 and 2017, the database included 3.6 million unique individuals, of whom 75% were Chinese, 8.6% Malay, 7.9% Indian, and 8.4% Others. Of those, 413 486 (11%) had diabetes. Major amputation rates in people with diabetes remained stable (2008: 99.5/100 000; 2017: 95.0/100 000 people with diabetes, p = .91) as did toe/ray amputation rates. Rates in people without diabetes were substantially lower, with major amputation rates decreasing significantly (2008: 3.0/100 000; 2017: 2.1/100 000 people without diabetes, 3% annual reduction, p = .048). Diabetes related amputation rates were highest in Malays and lowest in Chinese. Diabetes related major amputation rates declined significantly among Chinese (3.1% annual reduction, p < .038). While the RR for amputations in diabetes remained stable, the proportion of major amputations attributable to diabetes increased from 63.6% in 2008 to 81.7% in 2017 (3% annual increase, p = .003).
CONCLUSION: Diabetes related major and toe/ray amputation rates have remained stable but relatively high in Singapore compared with other countries, and the proportion of amputations attributable to diabetes has increased over time. More research is needed to understand the aetiopathological, sociocultural, and health system factors that may underlie the continued high rates of diabetes related amputations in this population.
Copyright © 2021 European Society for Vascular Surgery. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amputation trends; Asia; Epidemiology; Ethnic groups; Lower extremity amputation

Mesh:

Year:  2021        PMID: 34916107     DOI: 10.1016/j.ejvs.2021.09.041

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  3 in total

1.  Identification of Secondary Biomechanical Abnormalities in the Lower Limb Joints after Chronic Transtibial Amputation: A Proof-of-Concept Study Using SPM1D Analysis.

Authors:  Amr Alhossary; Wei Tech Ang; Karen Sui Geok Chua; Matthew Rong Jie Tay; Poo Lee Ong; Tsurayuki Murakami; Tabitha Quake; Trevor Binedell; Seng Kwee Wee; Min Wee Phua; Yong Jia Wei; Cyril John Donnelly
Journal:  Bioengineering (Basel)       Date:  2022-06-30

2.  Trends in diabetes-related complications in Singapore, 2013-2020: A registry-based study.

Authors:  Joshua Kuan Tan; Nur Nasyitah Mohamed Salim; Gek Hsiang Lim; Sing Yi Chia; Julian Thumboo; Yong Mong Bee
Journal:  PLoS One       Date:  2022-10-11       Impact factor: 3.752

3.  Temporal trends in patients with peripheral artery disease influenced by diabetes mellitus in Germany.

Authors:  Volker H Schmitt; Lukas Hobohm; Markus Vosseler; Christoph Brochhausen; Thomas Münzel; Christine Espinola-Klein; Karsten Keller
Journal:  J Diabetes       Date:  2022-09-22       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.